NFKB1 and cervical cancer: Both in vitro and in vivo studies conducted earlier in our laboratory have demonstrated the efficacy of curcumin in sensitizing cervical cancer cells towards paclitaxel, wherein significant down-regulation of several survival pathways was observed, though NF-κB was the key regulatory molecule [10, 11].